novo tirzepatide FDA confirms shortage is still over, gives compounders a grace period Lilly, Novo fight surge in

For example, SGLT2i use leads to a 33% reduction (95% CI 26, 38) in hospitalisation for heart failure (HF) and a 35% reduction (95% CI 19, 47) in the incidence of end-stage kidney disease (ESKD) [3, 4], and GLP-1 RA use leads to a 10% reduction (95% CI 2, 17) in myocardial infarction (MI) and a 17% reduction (95% CI 8, 24) reduction in stroke [2]

More recently, Ozempics approved uses have expanded beyond blood sugar control

1 and Extended Data Fig

Practical Storage Tips for Your Tirzepatide Injection at Home Store unopened tirzepatide vials in the main body of your refrigeratornot the doorin a small labeled container or drawer

however, the majority have included placebo-controlled trials or studies incorporating combination therapies